Retatrutide is a new medication in the fight against obesity. This revolutionary drug, categorized as a dual GLP-1 and GIP receptor agonist, exhibits promising results in clinical trials. By boosting these receptors, Retatrutide suppresses appetite, {promotesenergy expenditure, and ultimately aod 96